Next-generation regulatory T cell therapy

LMR Ferreira, YD Muller, JA Bluestone… - Nature reviews Drug …, 2019 - nature.com
Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …

Interleukin-2 and regulatory T cells in rheumatic diseases

AGA Kolios, GC Tsokos, D Klatzmann - Nature Reviews Rheumatology, 2021 - nature.com
Failure of regulatory T (Treg) cells to properly control immune responses leads invariably to
autoimmunity and organ damage. Decreased numbers or impaired function of Treg cells …

Guidelines for the use of flow cytometry and cell sorting in immunological studies

A Cossarizza, HD Chang, A Radbruch… - European journal of …, 2021 - Wiley Online Library
The third edition of Flow Cytometry Guidelines provides the key aspects to consider when
performing flow cytometry experiments and includes comprehensive sections describing …

Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity

K Piekarska, Z Urban-Wójciuk, M Kurkowiak… - Nature …, 2022 - nature.com
Cell-based immunotherapies can provide safe and effective treatments for various disorders
including autoimmunity, cancer, and excessive proinflammatory events in sepsis or viral …

Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease

N Richardson, GE Wootton, AG Bozward… - Seminars in …, 2022 - Springer
Autoimmune liver diseases (AILD) include autoimmune hepatitis (AIH), primary biliary
cholangitis (PBC) and primary sclerosing cholangitis (PSC). These immune-mediated liver …

Therapeutic potential of interleukin-2 in autoimmune diseases

Y Yuan, AGA Kolios, Y Liu, B Zhang, H Li… - Trends in Molecular …, 2022 - cell.com
Autoimmune diseases are characterized by dysregulation and aberrant activation of cells in
the immune system. Therefore, restoration of the immune balance represents a promising …

Future prospects for CD8+ regulatory T cells in immune tolerance

L Flippe, S Bézie, I Anegon… - Immunological …, 2019 - Wiley Online Library
CD8+ Tregs have been long described and significant progresses have been made about
their phenotype, their functional mechanisms, and their suppressive ability compared to …

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

ML MacMillan, KL Hippen, DH McKenna… - Blood …, 2021 - ashpublications.org
Abstract Human CD4+ 25− T cells cultured in interleukin 2 (IL-2), rapamycin, and
transforming growth factor β (TGFβ) along with anti-CD3 monoclonal antibody–loaded …

Engineered Treg cells: The heir to the throne of immunotherapy

A Stucchi, F Maspes, E Montee-Rodrigues… - Journal of …, 2024 - Elsevier
Recently, increased interest in the use of Tregs as adoptive cell therapy for the treatment of
autoimmune diseases and transplant rejection had led to several advances in the field …

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

MJ Mansilla, S Presas-Rodríguez… - Cellular & Molecular …, 2021 - nature.com
Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to
middle-aged adults, affecting~ 2.5 million people worldwide. Currently, most therapeutics for …